Roquette, a producer of plant-based ingredients and vegetal proteins, agreed to acquire pharma solutions business of IFF, a developer and manufacturer of pharmaceutical excipients, for $2.85bn. "We are excited to enter into this partnership with the talented Pharma Solutions team at IFF, which has grown into the go-to partner in the pharmaceutical excipients and specialty solutions markets globally. The combination of our excipients expertise with IFF Pharma is a fantastic opportunity to become a true global specialist of drug delivery and oral dosage solutions, responding to the needs of our customers and to the demands of patients who are looking for continuously better treatments,” Pierre Courduroux, Roquette CEO.